Pradžia › Plaučių ligos › Minesota
Plaučių ligos klinikiniai tyrimai Minesota
7 tyrimai dėl Plaučių ligos ieško dalyvių vietose Minesota.
Miestai Minesota
Oficialus tyrimo tekstas (anglų kalba)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Saint Paul
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT05624450A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Headlands Research-Twin Cities, Maplewood
Renkami dalyviai2 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07759245A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- HealthPartners Cancer Research Center, Saint Paul
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT06119581A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 108, Rochester
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-11 · NCT07555483Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of Minnesota, Minneapolis
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-06-26 · NCT04614103Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-19 · NCT02984761Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-09-29 · NCT04555161Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.